Resverlogix Corp
TSX:RVX

Watchlist Manager
Resverlogix Corp Logo
Resverlogix Corp
TSX:RVX
Watchlist
Price: 0.135 CAD -35.71% Market Closed
Market Cap: 38.3m CAD

P/OCF
Price to OCF

-8.7
Current
-4.6
Median
20.3
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-8.7
=
Market Cap
38.3m CAD
/
Operating Cash Flow
-3.2m USD
Market Cap P/OCF
CA
Resverlogix Corp
TSX:RVX
38.3m CAD -8.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -212 088.8
US
Abbvie Inc
NYSE:ABBV
336.1B USD 20.5
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD -14 473.5
US
Amgen Inc
NASDAQ:AMGN
164.8B USD 13.5
US
Gilead Sciences Inc
NASDAQ:GILD
144.7B USD 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD -123.1
US
Epizyme Inc
F:EPE
94.1B EUR -530.4
AU
CSL Ltd
ASX:CSL
129.7B AUD 28.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.9B USD 15.4
US
Seagen Inc
F:SGT
39.3B EUR -85.6
 
CA
Resverlogix Corp
TSX:RVX
Average P/OCF: 18.4
Negative Multiple: -8.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 088.8
US
Abbvie Inc
NYSE:ABBV
20.5
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -14 473.5
US
Amgen Inc
NASDAQ:AMGN
13.5
US
Gilead Sciences Inc
NASDAQ:GILD
14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -123.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.4
AU
CSL Ltd
ASX:CSL
28.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -85.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A